BackgroundMicrotubule-targeting agents, such as taxanes (paclitaxel and docetaxel) and vinca alkaloids (vincristine and vinblastine), act by suppressing microtubule dynamics and disrupting mitotic spindle configuration.1 These compounds are cell cycle specific, arresting the cell cycle in the G 2 /M phase.2 Because G 2 /M cells are most radiosensitive, these agents have been investigated as radiosensitizers. The combination of chemotherapy and radiation therapy indeed presents a number of advantages: because radiation is a local therapy and chemotherapy targets systemic spread, spatial co-operation of both modalities may participate in reduced local failure rates, eradication of micro metastases, improved distant control, organ function preservation and decreased tumor mass prior to surgery making complete resection possible.3 A clinical limitation to these combination therapies is the acquired or intrinsic resistance of tumors to established microtubule-targeting agents. Pyrrolo-1,5-benzoxazepines (PBOX) are a family of novel compounds with anticancer properties. We have previously demonstrated that several PBOX compounds induce apoptosis in a number Background: We proposed to investigate the radiosensitizing properties of pBOX-15, a novel microtubule-disrupting agent, in a panel of cancer cell lines.Results: pBOX-15 treatment was associated with significant cell kill and increased radiosensitivity in all three cell lines tested. The number of surviving cells in response to the combined treatment was significantly less than pBOX-15 alone in 22Rv1 cells. In these cells, radiosensitisation correlated with induction of G 2 /M cell cycle arrest by pBOX-15. The compound sustained its activity and increased hIF-1α expression under hypoxic conditions. pBOX-15 prevented onset of hypoxia-induced radioresistance in hypoxic prostate cells and reduced the surviving fraction of irradiated hypoxic cells to levels similar to those achieved under aerobic conditions. Methods: Clonogenic assays were used to determine sensitivity of a panel of cancer cell lines (22Rv1, a549, U87) to pBOX-15 alone or in combination with a single 2 Gy dose fraction. Induction of cell cycle arrest and apoptosis was investigated in 22Rv1 prostate cancer cells. The cytotoxic properties of the compound under hypoxic conditions were correlated with hypoxia Inducible Factor 1alpha (hIF-1α) gene and protein expression levels and its radiosensitisation potential was investigated in hypoxic 22Rv1 using clonogenic assays.Conclusions: This preliminary data identifies the potential of pBOX-15 as a novel radiosensitising agent for the management of solid tumors and eradication of hypoxic cells.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.